“We are very pleased with our strong preliminary revenue performance in the fourth quarter as the team executed exceptionally well and finished the year with significant momentum,” said Tim Herbert, Chairman and Chief Executive Officer of Inspire Medical (INSP) Systems. “We are also excited to announce the first implants of the new Inspire V neurostimulation system, and a new organizational structure intended to further fuel our continued growth, including the expansion of our leadership team with the hiring of a new Chief Manufacturing and Quality Officer.”
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INSP:
- Inspire Medical sees Q4 revenue $239.5M-$239.7M, consensus $232.9M
- CMS confirms to CNBC Medicare plans can now cover Zepbound for sleep apnea
- Target downgraded, Chewy upgraded: Wall Street’s top analyst calls
- Inspire Medical upgraded to Buy at BofA on durable margin upside
- Inspire Medical upgraded to Buy from Neutral at BofA